Abstract
Patients with relapsed or refractory non-Hodgkin's lymphomas (NHL) and Hodgkin's disease (HD) with recurrences after an anthracyclin-containing regimen only have a chance of cure of below 10% with conventional chemotherapy. In order to improve their prognosis, we started a phase I/II trial using high-dose therapy comprising carboplatin, together with etoposide and ifosfamide (CEI), followed by autologous stem cell rescue (ASCR) as consolidation after salvage treatment. Since September 1990, 40 patients with intensively pretreated advanced NHL (n = 24) or HD (n = 16) received one cycle of high-dose therapy (HDT) consisting of carboplatin 1500 mg/m2, ifosfamide 10 g/m2 and etoposide in escalating doses from 1200 mg/m2 to 2400 mg/m2 followed by ASCR. Thirty-nine patients were assessable for toxicity and response. The following doses appeared to be safe: carboplatin 1500 mg/m2, etoposide 2400 mg/m2 and ifosfamide 10 g/m2. All patients developed grade 3 nausea and grade 3 or 4 mucositis. Granulocytopenic fever occurred in 100% with grade 4 infections in 15%. Mild transient kidney toxicity was noted in 36% and liver toxicity in 20% of patients. One toxic death occurred (2.5%). Objective responses were obtained in 36 of 39 patients (9...Continue Reading
Citations
Apr 13, 2001·Cancer·L VillelaE Montserrat
Sep 16, 2004·Springer Seminars in Immunopathology·Yago NietoElizabeth J Shpall
Feb 19, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·O RickW Siegert
Jul 26, 2012·Blood Cancer Journal·N K El-MallawanyM S Cairo
Jun 14, 2001·British Journal of Haematology·Y YamadaM Shimoyama
Aug 24, 2006·International Journal of Hematology·Li-na HanTakaaki Chou
Sep 24, 1999·Leukemia & Lymphoma·F B Hagemeister
Dec 1, 2011·Expert Opinion on Investigational Drugs·Antonio Gualberto
Apr 27, 2004·Cancer·Stephen T SonisUNKNOWN International Society for Oral Oncology
Sep 17, 2013·Pediatric Blood & Cancer·Lisa Giulino-RothFarid Boulad
Mar 24, 2009·European Urology·Roisin M Connolly, John A McCaffrey
Jun 19, 2013·Best Practice & Research. Clinical Haematology·Catherine Lai, Kieron Dunleavy
Aug 17, 2011·Current Oncology Reports·Eileen M Boyle, Franck Morschhauser
Feb 11, 2016·World Journal of Clinical Oncology·Clarke Brian Blackadar
Sep 2, 2008·Infection·Y SakrK Reinhart
Jul 20, 2021·Expert Review of Hematology·Yuqin SongJun Zhu